Minnetonka, Minn., USA –
Syngenta today announced a lettuce germplasm acquisition from Salinas, Calif.-based Eagle Research and Development, Inc. (ERDI). The purchase enables Syngenta to expand its lettuce germplasm pool at an accelerated pace and complement its own in-house breeding efforts to meet evolving customer needs for new iceberg lettuce varieties for the U.S. lettuce market.
This germplasm acquisition will also allow Syngenta to enhance its tipburn resistance offering – a key driver in iceberg lettuce variety selection – and offer expanded plant performance characteristics for winter slot plantings. Tipburn is characterized by browning of the leaf edges of young, maturing leaves.
“This is an excellent opportunity to combine Eagle germplasm with Syngenta’s strong disease resistance package,” said Rick Mitchell, Vegetables Business Manager at Syngenta. “We will now be able to offer customers in the U.S. market additional options for a more complete iceberg lettuce portfolio.”
Founded in 1975 by David Williams, ERDI is a company specializing in lettuce breeding. For the past 40 years, Williams and ERDI have focused on improving lettuce production, harvesting, transportation, and breeding. ERDI breeding projects have included work on disease resistance and the development of better commercial quality lettuce. In 2012, Williams was inducted into the National Steinbeck Center’s Valley of the World Hall of Fame in recognition of his lifetime of work in furthering agricultural research.
“We are extremely proud of Dave’s breeding history and his many contributions to the lettuce industry in general,” Mitchell added. “It was his reputation in part which attracted us to him and we look forward to continuing his legacy of innovation.”
About Syngenta
Syngenta is one of the world's leading companies with more than 28,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers, we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us, please go to
www.syngenta.com.
Media Contacts:
Pam Molitor
612.656.8146
pam.molitor@syngenta.com
Brad Bremer
212.697.2600
bbremer@gibbs-soell.com
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as ‘expect’, ‘would’, ‘will’, ‘potential’, ‘plans’, ‘prospects’, ‘estimated’, ‘aiming’, ‘on track’ and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties including the “Risk Factors” in our Annual Report on Form 20-F. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract thereof.
The Syngenta logo is a registered trademark of a Syngenta Group Company.